Literature DB >> 21091165

New regimens with combined oral contraceptive pills--moving away from traditional 21/7 cycles.

Christine M Read1.   

Abstract

The practice of extending combined oral contraceptive use (COC) and eliminating or reducing the hormone free interval has been in use for many years. More recently a range of products with new dosing options has been developed and marketed. Women and physicians in developed countries are comfortable with and many prefer the use of extended COC regimens which provide an option to eliminate or reduce the frequency of regular withdrawal bleeding. The extension of active pill taking and the reduction or elimination of the hormone-free interval have been shown to be beneficial for women who experience menstrual cycle-related problems such as heavy bleeding or dysmenorrhoea. The hormone-free interval of less than seven days has additional benefits in managing hormone withdrawal symptoms and efficacy may be improved in situations where pills are inadvertently missed or in women who are perceived as 'poor' pill takers. This paper provides a descriptive review highlighting the development of new dosing options that alter the traditional 21/7 COC regimen. The rationale for and the acceptability of COCs developed with alternative dosing regimens is examined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091165     DOI: 10.3109/13625187.2010.529969

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  7 in total

1.  Types of combined oral contraceptives used by US women.

Authors:  Kelli Stidham Hall; James Trussell
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

Review 2.  The creeping Pearl: Why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?

Authors:  James Trussell; David Portman
Journal:  Contraception       Date:  2013-04-11       Impact factor: 3.375

3.  Nomegestrol acetate/estradiol: in oral contraception.

Authors:  Lily P H Yang; Greg L Plosker
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

4.  Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.

Authors:  Diana Mansour; Carole Verhoeven; Werner Sommer; Edith Weisberg; Surasak Taneepanichskul; Gian Benedetto Melis; Inger Sundström-Poromaa; Tjeerd Korver
Journal:  Eur J Contracept Reprod Health Care       Date:  2011-10-13       Impact factor: 1.848

5.  Nomegestrol acetate-17b-estradiol for oral contraception.

Authors:  Anne Burke
Journal:  Patient Prefer Adherence       Date:  2013-06-27       Impact factor: 2.711

6.  A chewable low-dose oral contraceptive: a new birth control option?

Authors:  Edith Weisberg
Journal:  Patient Prefer Adherence       Date:  2012-04-24       Impact factor: 2.711

7.  Offering extended use of the combined contraceptive pill: a survey of specialist family planning services.

Authors:  Ulrike Sauer; Sue Mann; Nataliya Brima; Judith Stephenson
Journal:  Int J Womens Health       Date:  2013-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.